Groowe Groowe / Newsroom / RANI
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

RANI News

Rani Therapeutics Holdings, Inc. Class A Common Stock

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

globenewswire.com
RANI

Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica

globenewswire.com
VKTX LLY NVO MRK FSK TSN KDP PEP MNDO THG ENTX RANI

Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors

businesswire.com
CVRX TAK ICON RANI BAX MDT BDX JNJ

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

globenewswire.com
RANI

Rani Therapeutics to Participate in the Evercore Healthcare Conference

globenewswire.com
RANI

Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight

prnewswire.com
AMGN UCB ENTX RANI ANGI

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

globenewswire.com
RANI

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

globenewswire.com
RANI

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

globenewswire.com
RANI

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

globenewswire.com
RANI